Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
VXM01 phase I dose escalation study in patients with locally advanced, inoperable and stage IV pancreatic cancer to examine safety, tolerability, and immune response to the investigational VEGFR-2 DNA vaccine VXM01

Proposed period of release:
01/11/2011 to 30/10/2012

Name of the Institute(s) or Company(ies)
VAXIMM GmbH, MAFINEX-Technologiezentrum
Julius-Hatry-Stra├če 1
68163 Mannheim;

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:

Identity of the GMO:
Proteobacteria, Gammaproteobacteria

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
S. TyphiEnterobacteriaceaesalmonellaentericaTy21aSerotype Typhi

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known